CD4 and ovarian cancer: These results revealed that artesunate promoted Th1 differentiation of peripheral CD4+ T cells, activated lymphocytes in the tumor microenvironment, and upregulated miR-142 expression in peripheral CD4+ T cells of ovarian cancer mouse model.